Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenues:        
Product revenues $ 1,066,551 $ 774,054 $ 2,432,705 $ 1,750,925
Other service revenues 37,330 29,249 65,311 62,781
Development services revenues 22,438 22,438
Total revenues 1,103,881 825,741 2,498,016 1,836,144
Cost of product revenues 520,987 394,821 1,217,533 780,430
Research and development costs 749,942 426,931 1,407,134 954,443
Selling, general, and administrative expenses 1,888,056 2,187,393 3,862,305 4,476,053
Restructuring charges 499,184 1,252,584
Operating loss (2,055,104) (2,682,588) (3,988,956) (5,627,366)
Other income (expense):        
Gain (loss) from change in fair value of derivative liabilities 263,927 (186,304) 424,045 (969,106)
Gain from debt restructuring 121,224 121,224
Other income, net 139,239 115,522 214,380 198,209
Interest income 2,125 4,744 6,458 12,195
Interest expense (253,375) (311,525) (602,933) (619,337)
Net loss $ (1,781,964) $ (3,060,151) $ (3,825,782) $ (7,005,405)
Net loss per share attributable to common stockholders:        
Basic and diluted (in dollars per share) $ (0.90) $ (2.08) $ (1.66) $ (4.73)
Weighted average shares outstanding:        
Basic and diluted (in shares) 1,971,071 1,472,998 2,309,537 1,481,021